GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Advagene Biopharma Co 6709.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

21.60

+3.85%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Net income

−TWD 68.3m

FY2016FY2025

Free cash flow

−TWD 65.6m

FY2016FY2025

Shareholders' equity

TWD 152.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Research and developmentTWD 50.3mTWD 50.3mTWD 73.2mTWD 100.0mTWD 72.7mTWD 55.3mTWD 70.7mTWD 105.4mTWD 130.9mTWD 63.8m
Operating income−TWD 70.9m−TWD 70.8m−TWD 92.1m−TWD 118.3m−TWD 92.6m−TWD 70.1m−TWD 98.8m−TWD 125.7m−TWD 149.5m−TWD 91.2m
Net income−TWD 68.3m−TWD 69.4m−TWD 92.1m−TWD 118.4m−TWD 92.7m−TWD 70.2m−TWD 91.6m−TWD 111.3m−TWD 138.1m−TWD 90.7m
Diluted earnings per share-1.28-1.30-1.79-2.40-1.88-1.58-1.72-2.09-2.59-3.96

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 166.5mTWD 232.2mTWD 147.9mTWD 140.8mTWD 260.4mTWD 316.3mTWD 279.2mTWD 358.8mTWD 226.2mTWD 149.5m
Cash and short-term investments——TWD 125.2mTWD 103.0mTWD 223.8mTWD 273.5mTWD 238.0m——TWD 123.8m
Total liabilitiesTWD 14.3mTWD 11.7mTWD 8.0mTWD 9.1mTWD 10.8mTWD 16.9mTWD 7.9mTWD 11.9mTWD 12.5mTWD 8.5m
Debt——TWD 870,000TWD 2.6mTWD 4.4mTWD 6.2m————
Shareholders' equityTWD 152.3mTWD 220.5mTWD 140.0mTWD 131.8mTWD 249.6mTWD 299.3mTWD 271.4mTWD 346.9mTWD 213.7mTWD 141.0m
Shares outstanding53m53m51m49m49m45m53m53m53m23m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 63.3m−TWD 70.6m−TWD 77.7m−TWD 109.4m−TWD 67.2m−TWD 30.9m−TWD 35,691−TWD 39.5m−TWD 177.0m−TWD 140.5m
Capital spending−TWD 2.3m−TWD 476,000—−TWD 10.2m−TWD 521,000−TWD 627,000−TWD 6.0m−TWD 342,000−TWD 544,000−TWD 5.5m
Free cash flow−TWD 65.6m−TWD 71.1m−TWD 77.7m−TWD 119.6m−TWD 67.7m−TWD 31.5m−TWD 6.1m−TWD 39.8m−TWD 177.6m−TWD 145.9m

Latest quarters

By quarter end

Dec 2025Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023
Operating income−TWD 36.4m−TWD 34.5m−TWD 38.7m−TWD 16,064−TWD 16,064−TWD 22,969−TWD 22,969−TWD 23,699
Net income−TWD 35.2m−TWD 33.1m−TWD 38.0m−TWD 15.7m−TWD 15.7m−TWD 22.7m−TWD 22.7m−TWD 23.3m
Diluted earnings per share-0.59-0.56-0.68-0.30-0.30-0.44-0.44-0.45
Cash from operations−TWD 30.0m−TWD 32.0m−TWD 43.0m—————
Capital spending−TWD 2.0m———————
Free cash flow−TWD 32.0m———————
Total assetsTWD 166.5mTWD 197.3mTWD 232.2mTWD 126.5mTWD 126.5mTWD 147.9mTWD 147.9mTWD 93.9m
Cash and short-term investments———TWD 96.5mTWD 96.5mTWD 125.2mTWD 125.2mTWD 61.4m
Debt—————TWD 870,000—TWD 1.6m
Shareholders' equityTWD 152.3mTWD 187.5mTWD 220.5mTWD 108.6mTWD 108.6mTWD 140.0mTWD 140.0mTWD 85.1m

Financial ratios

Data as of 2 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Return on equity-44.9%-31.5%-65.8%-89.8%-37.1%-23.4%
Return on assets-41.0%-29.9%-62.3%-84.1%-35.6%-22.2%
Free cash flow yield—-5.7%—-8.7%-5.9%-3.0%
Earnings growth-1.6%-24.6%-22.2%27.7%32.1%-23.4%
Current ratio13.69x31.63x18.37x14.94x29.50x23.47x
Debt to equity——0.01x0.01x0.01x0.01x
Equity ratio91.4%95.0%94.6%93.6%95.8%94.6%
Interest coverage-389.22x-458.74x-2557.61x-1460.44x-728.81x-654.72x
Buybacks as a share of market value—-3.5%-4.2%-0.1%-10.7%—

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-15.7%0.2%4.6%
Net income-16.8%-0.5%4.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-21.9-15.7-14.6-12.4-25.3-20.8-11.4-12.2

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.